By Nils Harder
About 7 min read

Retinol and retinoids: understanding skin ageing

Retinol can be converted in skin through retinal into retinoic acid, which helps regulate cellular processes. That link has led researchers to study both visible wrinkles and changes in the epidermis and supporting tissue underneath. Retinol is a form of vitamin A. Like retinal and retinoic acid, it belongs to the retinoid family.1

An unlabelled amber dropper bottle beside cream and a white towel.
A dropper bottle and cream as a skincare illustration. AI-generated.

Skin ageing involves the surface and connective tissue

Skin ageing involves internal processes and external influences. Even skin protected from the sun changes with age. In skin regularly exposed to sunlight, repeated UV exposure adds further changes. This additional component is called photoageing. A rougher surface, uneven pigmentation and wrinkles involve different structures.1

Think of skin in layers. On the outside, the stratum corneum and the lipids between its cells form part of the skin barrier. Living layers of the epidermis sit underneath. Deeper still, in the dermis, collagen and elastin are among the components of the supporting tissue. UV exposure can alter both the breakdown of these matrix components and the formation of collagen. Skin-ageing research therefore looks beneath visible appearance to cells and tissue as well.1

Wrinkles and pigmentation changes are visible at the surface. Changes in the supporting tissue become apparent when the tissue itself is examined. Skin-ageing research looks at both.

Distinguishing retinol, retinal and retinoic acid

Retinal, also known as retinaldehyde, is the intermediate in the conversion of retinol to retinoic acid. Retinyl esters such as retinyl palmitate can first be converted to retinol. The similar names describe different molecules in the same family.1

From retinol to retinoic acidSelected conversion pathway: retinol can be converted through retinal into retinoic acid. Retinoic acid binds to receptors in the cell nucleus that influence gene transcription. This shows a relationship between substances, not a ranking of finished products.One conversion pathway in skinRetinolA form of vitamin ARetinalalso called retinaldehydeRetinoic acidall-trans: tretinoinbinds toReceptors in the cell nucleusinfluence gene transcriptionSelected pathway, not a product ranking.Formulation and stability also matter.
A selected conversion pathway in skin. Arrows connect substances and receptor binding, not product strengths or application steps.1
SubstanceMetabolic contextWhat its name explains on a product
Retinyl estersCan provide retinolThese are different forms of vitamin A from free retinol.
RetinolPrecursor of retinal and retinoic acidFurther conversion is needed to form retinoic acid.
RetinalIntermediate on the route to retinoic acidA shorter metabolic route alone does not describe a finished skin-care product.
Retinoic acidAll-trans-retinoic acid is called tretinoinThe medicinal substance is assessed separately from cosmetic retinol skin care.

Retinoic acid binds to specific receptors in the cell nucleus. Working with other receptor proteins, these influence which genes are read, including processes involved in skin-cell development and differentiation. Differentiation is how cells take on their particular form and role. For a finished product, the vehicle, stability, amount of ingredient available and conditions in which it was studied also matter.1

What has been studied in human skin

A controlled study in older adults compared two areas of arm skin over 24 weeks. One received a retinol lotion and the other its vehicle without retinol. Fine wrinkles decreased more with the retinol lotion on the scale used. Small tissue substudies also found changes in water-binding skin components and a marker of collagen formation. These findings concern the lotion studied and the arm skin of very old adults.2

A short-term retinol experiment in human skin found changes in the epidermis and retinoid-binding proteins. It used covered skin areas, conditions different from ordinary facial skin care. Another investigation in photodamaged skin found increased formation of type I collagen precursors with the medicinal substance tretinoin. Visible wrinkles, these precursors and the amount of mature collagen are different measures.34

To judge what a finding says about a product, check which formulation the study tested. A 2024 systematic review describes numerous comparisons with tretinoin while highlighting quality problems and risks of bias in many studies. One split-face investigation compared a combined retinoid formulation with either retinol or tretinoin. It compared particular products rather than establishing a general ranking of all retinoids.56

Why formulation and packaging belong in the picture

Light and air can alter retinol. That makes formulation part of understanding the ingredient: it helps determine how retinol is preserved in a product and delivered to skin. When comparing two products, look beyond the retinol percentage to the vehicle, stability information and storage instructions. Packaging alone does not tell you how long the contents will remain stable.1

When comparing products, separate the ingredient name, what the concentration refers to and the data on the finished formula. Check the manufacturer’s storage and use instructions too. The ingredient name alone does not tell you how soon to use up the product.

What EU limits and vitamin A exposure mean

Annex III entry 376 of the EU Cosmetics Regulation specifies maximum concentrations for retinol, retinyl acetate and retinyl palmitate of 0.05% retinol equivalent in body lotion and 0.3% in other leave-on and rinse-off products. Retinol equivalents provide a common reference for these forms of vitamin A. Retinal is not on this substance list. These EU provisions are safety and regulatory values rather than recommended starting concentrations.8

The regulation also requires a warning to consider daily vitamin A intake. Cosmetics add to exposure from food and supplements. The European scientific committee highlights consumers whose existing exposure is already high. An individual’s total exposure cannot be determined from the percentage on a serum alone.89

Since 1 November 2025, products containing these substances that do not comply with the conditions may no longer be made available on the Union market for the first time. From 1 May 2027, they may no longer be distributed or sold there either. Placing on the market means the first making available. Subsequent availability covers further distribution stages. This explanation is dated 5 November 2026.8

Irritation, pregnancy and medicines

Dryness, redness and flaking are possible reactions to skin care containing retinoids.1 Irritation is not a measure of a desired cosmetic effect. Irritated skin can also develop dark marks, particularly in darker skin tones. The American Academy of Dermatology discusses these issues in guidance that includes over-the-counter retinol products. Existing dry or inflamed skin therefore requires a different assessment from skin without those concerns.7

The society advises avoiding retinoids during pregnancy. Its discussion includes cosmetic retinol skin care. During pregnancy or when planning a pregnancy, specific skin-care products should be discussed with a clinician. For sun protection, it describes shade, clothing and suitable sunscreen on uncovered skin.7

Retinoid medicines form a separate product group. The EMA describes a risk to the unborn child from oral retinoid medicines. As a precaution, topical retinoid medicines must also not be used during pregnancy or when planning a pregnancy. This assessment of medicines and the society’s caution about cosmetics have different foundations. Medicinal retinoids belong in clinical care rather than a self-designed longevity plan.10

Reading product claims in light of the research

Human studies have examined changes in wrinkle scores, the epidermis and tissue markers. Each finding applies to the substance, formulation, skin area and outcome studied. Study quality affects how much weight it carries. These results do not establish a ranking of all products or tell us about human lifespan.

When reading a product description, the precise ingredient name, the basis of its concentration, data on the finished product and safety information are therefore more useful than the highest possible number. “Anti-ageing” brings together very different claims. An informed decision starts with identifying which of them has actually been investigated.

Looking closely at the tested product also helps with nutrition topics: Beef shank soup: meat, broth and gelatin separates the meal from studies of collagen peptides. Bryan Johnson: how he organises his Blueprint day shows how skincare fits into a publicly described biohacking routine.

This article explains research and product groups. It does not replace individual medical advice or treatment planning.

Sources

  1. Mukherjee et al. (2006): Retinoids in the treatment of skin aging. Scientific review covering skin structure, conversion, receptors and formulation stability.
  2. Kafi et al. (2007): Improvement of naturally aged skin with vitamin A. Controlled investigation in older adults, original abstract.
  3. Kang et al. (1995): Application of retinol to human skin. Short-term experiment, original abstract.
  4. Griffiths et al. (1993): Restoration of collagen formation in photodamaged human skin. Original investigation with tretinoin.
  5. Siddiqui et al. (2024): Comparing Tretinoin to Other Topical Therapies. Systematic review, original abstract.
  6. McDaniel et al. (2017): a combined retinoid formulation in a split-face comparison. Original summary.
  7. American Academy of Dermatology: Retinoid or retinol?. Professional society information, updated 25 May 2021.
  8. EU Cosmetics Regulation (EC) 1223/2009, consolidated version of 18 May 2026. Article 2(1)(g) and (h), and Annex III entry 376 with footnote 45; introduced by Regulation (EU) 2024/996. Accessed 5 November 2026.
  9. SCCS: Revision of the scientific opinion on vitamin A. Published conclusions of the final opinion from October 2022.
  10. EMA: Retinoid-containing medicinal products. Medicine safety and pregnancy.